Telegram VKontakte Yandex Youtube

Latest news

News

FDA approves first gene therapy for sickle cell disease in young children

The US Food and Drug Administration has expanded approval of Vertex Pharmaceuticals' Casgevy (exagamglogene autotemcel) to patients as young as two years old with...
News

Russia’s FMBA proposes space experiments to study radiation effects on drugs

The FMBA has proposed a series of space experiments aboard the Russian Orbital Station. The tasks include studying the effects of radiation on drug...
News

Russian drugmaker Promomed to test josamycin antibiotic in paediatric respiratory infections

Promomed has launched the JASMINE observational study to assess the efficacy and safety of the antibiotic Vilpramicin SAR (josamycin) for treating respiratory infections in...
News

Russian scientists link autism-like behaviours to mutation in Plau gene

Using a genetically modified mouse model, researchers have shown that a mutation in the Plau gene – which is involved in the migration of...
News

Roche’s decades‑old cancer drug rituximab helps some women with premature ovarian insufficiency conceive

A pilot study published in NEJM Evidence found that rituximab, a Roche cancer drug developed decades ago, may restore fertility in some women with...
News

New Russian generic of AbbVie’s paricalcitol enters market as Moscow boosts local drug supply

R‑Opra, part of the R‑Pharm group, has started producing Dekalpar (paricalcitol) for treating severe chronic kidney disease at the Technopolis Moscow special economic zone....
News

Ionis’s Tryngolza wins expanded approval for severe high triglycerides

The US Food and Drug Administration has approved Ionis Pharmaceuticals' Tryngolza (olezarsen) for the treatment of severe hypertriglyceridemia – a dangerous condition in which...
News

Russia’s SID & GP and China’s CFDI agree to collaborate on GMP inspections

Russia’s “State Institute of Drugs and Good Practices” (FSI “SID & GP”) and the Center for Food and Drug Inspection of China's National Medical...

Most popular

«GxP News» — зарегистрированный товарный знак. Использование названия на латинице осуществляется на основании свидетельства Роспатента № 920870 от 03.02.2023 г. в соответствии с п. 3 ст. 3 Федерального закона от 01.06.2005 № 53-ФЗ «О государственном языке Российской Федерации». Все права защищены. © 2019–2026 ООО «Медиа-Фарм Новости».

Воспроизведение материалов допускается только при соблюдении ограничений, установленных правообладателем, при указании автора используемых материалов и ссылки на портал GxP News как на источник заимствования.

18+

WordPress Ads